Skip to main content
Top
Published in: European Radiology 11/2014

01-11-2014 | Musculoskeletal

The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma

Authors: Julie C. Dutoit, Matthias A. Vanderkerken, Joris Anthonissen, Frederick Dochy, Koenraad L. Verstraete

Published in: European Radiology | Issue 11/2014

Login to get access

Abstract

Objectives

To evaluate DWI of the bone marrow in the differentiation of monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma (SMM) and multiple myeloma (MM).

Methods

The retrospective study includes 64 patients with MGUS, 27 with SMM, 64 with new MM and 12 controls. Signal intensity (SI) of spinal SE-MRI and DWI (b0-1000) as well as apparent diffusion coefficients (ADC) were measured in the T10 and L3. Qualitative assessment of b-images was performed by one experienced radiologist.

Results

ADC600 and ADC1000 are the best ADC values in differentiating patient groups (p < 0.030). SIT2, SIb1000 and ADC1000 are higher and SIT1 lower in L3 compared to T10 (p < 0.050). All quantitative parameters of L3 can differentiate significantly between MGUS and MM (p < 0.050) and between patients with percentage plasma cells (PC%) between 0-10 % compared to >50 % (p = 0.001). Only SIT2 for L3 can differentiate MGUS from SMM (p = 0.044) and PC%0-10 from PC%10-25 (p = 0.033). Qualitative interpretation of b1000 images allows differentiating MM patients from those with MGUS or SMM (p < 0.001).

Conclusions

Spinal SE-MRI can differentiate among MGUS, SMM, MM and control subjects. DWI based on the SI on b1000 images and ADC values is increased in MM compared to MGUS and SMM. Qualitative assessment of b-images can differentiate MM from MGUS or SMM.

Key points

ADC values are higher in patients with MM compared to MGUS
DWI parameters change late in disease evolution
DWI is sensitive but not specific in diagnosing patients with MM
Qualitative DWI assessment is good in detecting myeloma patients
Literature
1.
go back to reference Shah R, Stieltjes B, Andrulis M et al (2013) Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseases. Ann Hematol 92:1553–1557PubMedCrossRef Shah R, Stieltjes B, Andrulis M et al (2013) Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseases. Ann Hematol 92:1553–1557PubMedCrossRef
2.
go back to reference Dutoit JC, Vanderkerken MA, Verstraete KL (2013) Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. Eur J Radiol 82:1444–1452PubMedCrossRef Dutoit JC, Vanderkerken MA, Verstraete KL (2013) Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. Eur J Radiol 82:1444–1452PubMedCrossRef
3.
go back to reference Schmidt GP, Reiser MF, Baur-Melnyk A (2007) Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skelet Radiol 36:1109–1119CrossRef Schmidt GP, Reiser MF, Baur-Melnyk A (2007) Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skelet Radiol 36:1109–1119CrossRef
4.
go back to reference Padhani AR, van Ree K, Collins DJ, D'Sa S, Makris A (2013) Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI. AJR Am J Roentgenol 200:163–170PubMedCrossRef Padhani AR, van Ree K, Collins DJ, D'Sa S, Makris A (2013) Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI. AJR Am J Roentgenol 200:163–170PubMedCrossRef
5.
go back to reference Khoo MM, Tyler PA, Saifuddin A, Padhani AR (2011) Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review. Skelet Radiol 40:665–681CrossRef Khoo MM, Tyler PA, Saifuddin A, Padhani AR (2011) Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review. Skelet Radiol 40:665–681CrossRef
6.
go back to reference Petralia G, Thoeny HC (2010) DW-MRI of the urogenital tract: applications in oncology. Cancer Imaging 10 Spec no A:S112–S123PubMedCrossRef Petralia G, Thoeny HC (2010) DW-MRI of the urogenital tract: applications in oncology. Cancer Imaging 10 Spec no A:S112–S123PubMedCrossRef
7.
go back to reference Kitajima K, Takahashi S, Ueno Y et al (2013) Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer? Eur J Radiol 82:1219–1226PubMedCrossRef Kitajima K, Takahashi S, Ueno Y et al (2013) Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer? Eur J Radiol 82:1219–1226PubMedCrossRef
8.
go back to reference Dietrich O, Biffar A, Reiser MF, Baur-Melnyk A (2009) Diffusion-weighted imaging of bone marrow. Semin Musculoskelet Radiol 13:134–144PubMedCrossRef Dietrich O, Biffar A, Reiser MF, Baur-Melnyk A (2009) Diffusion-weighted imaging of bone marrow. Semin Musculoskelet Radiol 13:134–144PubMedCrossRef
9.
go back to reference Messiou C, Collins DJ, Morgan VA, Desouza NM (2011) Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radiol 21:1713–1718PubMedCrossRef Messiou C, Collins DJ, Morgan VA, Desouza NM (2011) Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radiol 21:1713–1718PubMedCrossRef
10.
go back to reference Padhani AR, Koh DM, Collins DJ (2011) Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 261:700–718PubMedCrossRef Padhani AR, Koh DM, Collins DJ (2011) Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 261:700–718PubMedCrossRef
11.
go back to reference Fenchel M, Konaktchieva M, Weisel K et al (2010) Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results. Eur Radiol 20:2899–2906PubMedCrossRef Fenchel M, Konaktchieva M, Weisel K et al (2010) Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results. Eur Radiol 20:2899–2906PubMedCrossRef
12.
13.
go back to reference Hillengass J, Bauerle T, Bartl R et al (2011) Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology. Br J Haematol 153:721–728PubMedCrossRef Hillengass J, Bauerle T, Bartl R et al (2011) Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology. Br J Haematol 153:721–728PubMedCrossRef
14.
go back to reference Hillengass J, Stieltjes B, Bauerle T et al (2011) Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals. Acta Radiol 52:324–330PubMedCrossRef Hillengass J, Stieltjes B, Bauerle T et al (2011) Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals. Acta Radiol 52:324–330PubMedCrossRef
15.
go back to reference International Myeloma Working G (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749–757CrossRef International Myeloma Working G (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749–757CrossRef
16.
go back to reference Landgren O, Korde N (2011) Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities. Oncology (Williston Park) 25:589–590 Landgren O, Korde N (2011) Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities. Oncology (Williston Park) 25:589–590
18.
go back to reference Narquin S, Ingrand P, Azais I et al (2013) Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma. Diagn Interv Imaging 94:629–636PubMedCrossRef Narquin S, Ingrand P, Azais I et al (2013) Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma. Diagn Interv Imaging 94:629–636PubMedCrossRef
19.
go back to reference Koh DM (2010) Qualitative and quantitative analyses: image evaluation and interpretation. In: Koh DM, Thoeny HC (eds) Diffusion-weighted MR imaging applications in the body. Springer, Heidelberg, pp 33–47CrossRef Koh DM (2010) Qualitative and quantitative analyses: image evaluation and interpretation. In: Koh DM, Thoeny HC (eds) Diffusion-weighted MR imaging applications in the body. Springer, Heidelberg, pp 33–47CrossRef
20.
go back to reference Padhani AR, Khan AA (2010) Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy. Target Oncol 5:39–52PubMedCrossRef Padhani AR, Khan AA (2010) Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy. Target Oncol 5:39–52PubMedCrossRef
21.
go back to reference Landgren O (2010) Monoclonal gammopathy of undetermined significance and smoldering myeloma: new insights into pathophysiology and epidemiology. Hematol Am Soc Hematol Educ Program 2010:295–302CrossRef Landgren O (2010) Monoclonal gammopathy of undetermined significance and smoldering myeloma: new insights into pathophysiology and epidemiology. Hematol Am Soc Hematol Educ Program 2010:295–302CrossRef
22.
go back to reference Silva JR Jr, Hayashi D, Yonenaga T et al (2013) MRI of bone marrow abnormalities in hematological malignancies. Diagn Interv Radiol 19:393–399PubMed Silva JR Jr, Hayashi D, Yonenaga T et al (2013) MRI of bone marrow abnormalities in hematological malignancies. Diagn Interv Radiol 19:393–399PubMed
23.
go back to reference Herrmann J, Krstin N, Schoennagel BP et al (2012) Age-related distribution of vertebral bone-marrow diffusivity. Eur J Radiol 81:4046–4049PubMedCrossRef Herrmann J, Krstin N, Schoennagel BP et al (2012) Age-related distribution of vertebral bone-marrow diffusivity. Eur J Radiol 81:4046–4049PubMedCrossRef
24.
go back to reference Savvopoulou V, Maris TG, Vlahos L, Moulopoulos LA (2008) Differences in perfusion parameters between upper and lower lumbar vertebral segments with dynamic contrast-enhanced MRI (DCE MRI). Eur Radiol 18:1876–1883PubMedCrossRef Savvopoulou V, Maris TG, Vlahos L, Moulopoulos LA (2008) Differences in perfusion parameters between upper and lower lumbar vertebral segments with dynamic contrast-enhanced MRI (DCE MRI). Eur Radiol 18:1876–1883PubMedCrossRef
25.
go back to reference Nakanishi K, Gutzeit A (2010) Evaluation of malignant bone disease using DW-MRI. In: Koh DM, Thoeny HC (eds) Diffusion-weighted MR imaging applications in the body. Springer, Heidelberg, pp 207–226CrossRef Nakanishi K, Gutzeit A (2010) Evaluation of malignant bone disease using DW-MRI. In: Koh DM, Thoeny HC (eds) Diffusion-weighted MR imaging applications in the body. Springer, Heidelberg, pp 207–226CrossRef
26.
go back to reference Vande Berg BC, Malghem J, Lecouvet FE, Maldague B (1998) Magnetic resonance imaging of the normal bone marrow. Skelet Radiol 27:471–483CrossRef Vande Berg BC, Malghem J, Lecouvet FE, Maldague B (1998) Magnetic resonance imaging of the normal bone marrow. Skelet Radiol 27:471–483CrossRef
27.
go back to reference Lecouvet FE, Larbi A, Pasoglou V et al (2013) MRI for response assessment in metastatic bone disease. Eur Radiol 23:1986–1997PubMedCrossRef Lecouvet FE, Larbi A, Pasoglou V et al (2013) MRI for response assessment in metastatic bone disease. Eur Radiol 23:1986–1997PubMedCrossRef
28.
go back to reference Nonomura Y, Yasumoto M, Yoshimura R et al (2001) Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging 13:757–760PubMedCrossRef Nonomura Y, Yasumoto M, Yoshimura R et al (2001) Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging 13:757–760PubMedCrossRef
29.
go back to reference Padhani AR, Gogbashian A (2011) Bony metastases: assessing response to therapy with whole-body diffusion MRI. Cancer Imaging 11 Spec No A:S129–S145PubMedCrossRef Padhani AR, Gogbashian A (2011) Bony metastases: assessing response to therapy with whole-body diffusion MRI. Cancer Imaging 11 Spec No A:S129–S145PubMedCrossRef
Metadata
Title
The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma
Authors
Julie C. Dutoit
Matthias A. Vanderkerken
Joris Anthonissen
Frederick Dochy
Koenraad L. Verstraete
Publication date
01-11-2014
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 11/2014
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3324-5

Other articles of this Issue 11/2014

European Radiology 11/2014 Go to the issue